GlassScriptPhysician profile
Michelle Wesley Clark
NPI 1881226462
$914.95
in general payments reported to CMS, 2019-2025
20 companies · $915 in 2025
The $915 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $815 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.96 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $171.51 | 2025 | Jakafi, Niktimvo, Monjuvi |
| Novartis Pharmaceuticals Corporation | $95.63 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.99 | 2025 | |
| Daiichi Sankyo INC. | $52.99 | 2025 | Enhertu |
| Springworks Therapeutics, INC. | $51.83 | 2025 | Gomekli, Ogsiveo |
| Janssen Biotech, INC. | $48.49 | 2025 | Tecvayli |
| Adaptive Biotechnologies Corporation | $44.05 | 2025 | Clonoseq |
| Astrazeneca Pharmaceuticals LP | $43.80 | 2025 | Enhertu, Imfinzi |
| Genentech USA, INC. | $39.45 | 2025 | Tecentriq, Itovebi |
| Merck Sharp & Dohme LLC | $35.28 | 2025 | Welireg, Keytruda, Keytruda Qlex |
| Glaxosmithkline, LLC. | $32.44 | 2025 | Ojjaara |
| Tersera Therapeutics LLC | $29.41 | 2025 | Zoladex |
| Caris Mpi, INC. | $27.53 | 2025 | Mi Cancer Seek |
| Genmab U.S., INC. | $26.51 | 2025 | Epkinly |
| Azurity Pharmaceuticals, INC. | $25.00 | 2025 | Danziten |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $24.90 | 2025 | |
| Immunocore Limited | $24.64 | 2025 | Kimmtrak |
| Puma Biotechnology, INC. | $24.08 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.58 | 2025 | |
| Eisai INC. | $15.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.